These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10845692)

  • 1. Release of mifepristone from biodegradable matrices: experimental and theoretical evaluations.
    Charlier A; Leclerc B; Couarraze G
    Int J Pharm; 2000 Apr; 200(1):115-20. PubMed ID: 10845692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
    Ozalp Y; Ozdemir N; Hasirci V
    J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the mechanism of release of the amphoteric drug amoxycillin from poly(D,L-lactide-co-glycolide) matrices.
    Mollo AR; Corrigan OI
    Pharm Dev Technol; 2002; 7(3):333-43. PubMed ID: 12229265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of protein diffusion through poly(D,L-lactide-Co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2005; 10(2):299-307. PubMed ID: 15926679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline.
    Webber WL; Lago F; Thanos C; Mathiowitz E
    J Biomed Mater Res; 1998 Jul; 41(1):18-29. PubMed ID: 9641620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution.
    Raman C; Berkland C; Kim K; Pack DW
    J Control Release; 2005 Mar; 103(1):149-58. PubMed ID: 15773062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers.
    Schmitt EA; Flanagan DR; Linhardt RJ
    J Pharm Sci; 1993 Mar; 82(3):326-9. PubMed ID: 8450430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer erosion in PLGA microparticles produced by phase separation method.
    Husmann M; Schenderlein S; Lück M; Lindner H; Kleinebudde P
    Int J Pharm; 2002 Aug; 242(1-2):277-80. PubMed ID: 12176263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres.
    Blanco-Príeto MJ; Besseghir K; Orsolini P; Heimgartner F; Deuschel C; Merkle HP; Nam-Trân H; Gander B
    Int J Pharm; 1999 Jul; 184(2):243-50. PubMed ID: 10387954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
    Niwa T; Takeuchi H; Hino T; Kunou N; Kawashima Y
    J Pharm Sci; 1994 May; 83(5):727-32. PubMed ID: 8071830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide).
    Kreitz MR; Domm JA; Mathiowitz E
    Biomaterials; 1997 Dec; 18(24):1645-51. PubMed ID: 9613812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of gamma-irradiation on drug release from bioerodible microparticles: a quantitative treatment.
    Faisant N; Siepmann J; Oury P; Laffineur V; Bruna E; Haffner J; Benoit J
    Int J Pharm; 2002 Aug; 242(1-2):281-4. PubMed ID: 12176264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic aspects of the release of levamisole hydrochloride from biodegradable polymers.
    Gallagher KM; Corrigan OI
    J Control Release; 2000 Nov; 69(2):261-72. PubMed ID: 11064133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A local delivery system for fentanyl based on biodegradable poly(L-lactide-co-glycolide) oligomer.
    Seo SA; Choi HS; Khang G; Rhee JM; Lee HB
    Int J Pharm; 2002 Jun; 239(1-2):93-101. PubMed ID: 12052694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro performance of carbamazepine loaded to various molecular weights of poly (D,L-lactide-co-glycolide).
    Barakat NS; Radwan MA
    Drug Deliv; 2006; 13(1):9-18. PubMed ID: 16401588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
    Frank A; Kumar Rath S; Boey F; Venkatraman S
    Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of poly-hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts.
    Mollo AR; Corrigan OI
    Int J Pharm; 2003 Dec; 268(1-2):71-9. PubMed ID: 14643978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods.
    Hsu YY; Gresser JD; Stewart RR; Trantolo DJ; Lyons CM; Simons GA; Gangadharam PR; Wise DL
    J Pharm Sci; 1996 Jul; 85(7):706-13. PubMed ID: 8818994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.